Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6- trans isomer: wherein R 2 , R 3 and R 4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.